Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors.
Saved in:
| Title: | Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors. |
|---|---|
| Authors: | Jim, Heather S. L.1 (AUTHOR) Heather.Jim@moffitt.org, Eisel, Sarah L.1 (AUTHOR) Aasha.Hoogland@moffitt.org, Hoogland, Aasha I.1 (AUTHOR), Shaw, Sandra2 (AUTHOR) sshaw@mjhlifesciences.com, King, Jennifer C.2 (AUTHOR) jking@go2foundation.org, Dicker, Adam P.3 (AUTHOR) Adam.Dicker@jefferson.edu |
| Source: | Cancers. Jan2021, Vol. 13 Issue 1, p103-103. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers13010103 |